Zdrowie i gospodarka · 16/01/2007

FDA Publishes Proposed Recommendations for Prescription Drug User Fee Act Reauthorization

The FDA is seeking public input on proposed recommendations for reauthorizing the Prescription Drug User Fee program, which covers human drug application review for FY 2008-2012, following discussions with industry, experts, and advocacy groups.